Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cipla Sees Changed Profile; Wraps Up Europe Revamp

Executive Summary

Cipla's management sees the firm's profile changing as it scales up its US business with new launches and a step-up in product filing intensity. The Indian company is also "largely done" with a restructuring in Europe that saw a significant cutback in personnel but is expected to make the European business profit-accretive.

Advertisement

Related Content

Cipla Signals US Launch Momentum, Commodity-Like Price Cycle
Cipla Trimming Jobs Amid Europe Business Rejig
Operational Fixes At Cipla But All Eyes On Generic Advair
Cipla Injects Scale With $550m US Buy
Cipla-Serum add new rung to relationship

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel